Cognition Therapeutics, Inc. (CGTX)
NASDAQ: CGTX · Real-Time Price · USD
1.280
0.00 (0.00%)
At close: Apr 28, 2026, 4:00 PM EDT
1.280
0.00 (0.00%)
After-hours: Apr 28, 2026, 6:32 PM EDT
Cognition Therapeutics Market Cap
Cognition Therapeutics has a market cap or net worth of $114.37 million as of April 28, 2026. Its market cap has increased by 477.81% in one year.
Market Cap
114.37M
Enterprise Value
79.09M
1-Year Change
477.81%
Ranking
Category
Stock Price
$1.28
Market Cap Chart
Since the IPO on October 8, 2021, Cognition Therapeutics's market cap has decreased from $256.46M to $114.37M, a decrease of -55.40%. That is a compound annual growth rate of -16.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 114.37M | -4.03% |
| Dec 31, 2025 | 119.17M | 308.99% |
| Dec 31, 2024 | 29.14M | -50.97% |
| Dec 29, 2023 | 59.43M | -2.39% |
| Dec 30, 2022 | 60.88M | -56.29% |
| Dec 31, 2021 | 139.27M | -45.69% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Verrica Pharmaceuticals | 119.91M |
| Oncolytics Biotech | 119.61M |
| Pyxis Oncology | 119.38M |
| NeOnc Technologies Holdings | 119.08M |
| Aardvark Therapeutics | 117.59M |
| Cardiff Oncology | 117.59M |
| Immunic | 114.82M |
| Cibus | 114.42M |